Treatment of Pneumocystis carinii pneumonia in infancy.
Pentamidine is recommended for the therapy of Pneumocystis carinii pneumonia either alone or, in severe cases, combined with pyrimethamine. Attention is drawn to the importance of supporting symptomatic treatment, particularly with the promethazine-Hydergine cocktail, and to the possibilities for general and drug prophylaxis.
D004088:Dihydroergotoxine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005492:Folic Acid / Q000378:metabolism; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy; D008297:Male; D010419:Pentamidine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy* / Q000517:prevention & control; D011398:Promethazine / Q000627:therapeutic use; D011739:Pyrimethamine / Q000494:pharmacology / Q000627:therapeutic use*
D004088:Dihydroergotoxine; D010419:Pentamidine; D005492:Folic Acid; D011398:Promethazine; D011739:Pyrimethamine